Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis-Reference-Cited by-同舟云学术

Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis

Published:2007 Issue:6 Volume:56 Page:1846-1853
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Maksymowych Walter P.,Landewé Robert,Conner-Spady Barbara,Dougados Maxime,Mielants Herman,van der Tempel Hille,Poole A. Robin,Wang Nandi,van der Heijde Désirée

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference37 articles.

1. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system

2. What is the most appropriate radiologic scoring method for ankylosing spondylitis?

3. How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured?

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positivity in serum MMP-3 after clinical remission or low disease activity at 52 weeks leads to future joint destruction in patients with rheumatoid arthritis;2024-04-21

2. Rapid screening for autoimmune diseases using Fourier transform infrared spectroscopy and deep learning algorithms;Frontiers in Immunology;2023-12-15

3. Male spondyloarthritis patients and those with longer disease duration have less severe disc degeneration: propensity score-matched comparison;Rheumatology Advances in Practice;2023-12-09

4. PRICKLE1 gene methylation and abnormal transcription in Chinese patients with ankylosing spondylitis;Immunobiology;2023-11

5. Matrix Metalloproteinases; A Biomarker of Disease Activity and Prognosis in Spondyloarthritis: A Narrative Review;Current Reviews in Clinical and Experimental Pharmacology;2023-03